Comparative genomic hybridization (CGH) analysis of neuroblastomas - An important methodological approach in paediatric tumour pathology

Journal of Pathology

Volumn 181, Issue 4, 1997, Pages 394-400

  Brinkschmidt, Christian ^a   Christiansen, Holger ^b   Terpe, Hans Joachim ^a   Simon, Ronald ^a   Boecker, Werner ^a   Lampert, Fritz ^b   Stoerkel, Stefan ^a  

^a UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^b JUSTUS LIEBIG UNIVERSITY   (Germany)

Author keywords

amplification; CGH; neuroblastoma

Indexed keywords

ONCOPROTEIN;

ARTICLE; CHILD; CHILDHOOD CANCER; CHROMOSOME 17; CHROMOSOME 1P; CHROMOSOME ABERRATION; CHROMOSOME DELETION; CLINICAL ARTICLE; FLUORESCENCE IN SITU HYBRIDIZATION; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; INFANT; NEUROBLASTOMA; ONCOGENE C MYB; PRIORITY JOURNAL; SOUTHERN BLOTTING;

BLOTTING, SOUTHERN; CHILD; CHILD, PRESCHOOL; CHROMOSOME ABERRATIONS; CHROMOSOME DELETION; CHROMOSOMES, HUMAN, PAIR 17; DNA, NEOPLASM; FEASIBILITY STUDIES; HUMANS; INFANT; NEUROBLASTOMA; NUCLEIC ACID HYBRIDIZATION; PROGNOSIS;

EID: 0030966604     PISSN: 00223417     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9896(199704)181:4<394::AID-PATH800>3.0.CO;2-1     Document Type: Article

References (29)

1. Crist WM, Kun LE. Common solid tumours of childhood. N Engl J Med 1984; 324: 461-471.
2. Christiansen H, Lampert F. Tumor karyotype discriminates between good and bad prognostic outcome in neuroblastoma. Br J Cancer 1988; 57: 121-126.
3. Look AT, Hayes FA, Shuster JJ, et al. Clinical relevance of tumor cell ploidy and N-myc amplification in childhood neuroblastoma: a pediatric oncology group study. J Clin Oncol 1991; 9: 981-991.
4. Seeger RC, Brodeur GM, Sather H, et al. Association of multiple copies of N-myc oncogene with rapid progression of neuroblastomas. N Engl J Med 1985; 313: 1111-1116.
5. Caron H, van Sluis P, de Kraker J, et al. Allelic loss of chromosome 1p as a predictor of unfavourable outcome in patients with neuroblastoma. N Engl J Med 1996; 334: 225-230.
6. Takita J, Hayashi Y, Kohno T, et al. Allelotype of neuroblastoma. Oncogene 1995; 11: 1829-1934.
7. Srivatsan ES, Ying KL, Seeger RC. Deletion of chromosome 11 and of 14q sequences in neuroblastoma. Genes Chrom Cancer 1993; 7: 32-37.
8. Suzuki T, Okota J, Mugishima H, et al. Frequent loss of heterozygosity on chromosome 14q in neuroblastoma. Cancer Res 1989; 49: 1095-1098.
9. Fong CT, White PS, Peterson K, et al. Loss of heterozygosity of chromosome 1 or 14 defines subsets of advanced neuroblastomas. Cancer Res 1992; 52: 1780-1785.
10. Caron H. Allelic loss of chromosome 1 and additional chromosome 17 material are both unfavourable prognostic markers in neuroblastoma. Med Pediatr Oncol 1995; 24: 215-221.
11. Kallioniemi A, Kallioniemi OP, Sudar D, et al. Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors. Science 1992; 258: 818-821.
12. Houldswourth J, Chaganti RS. Comparative genomic hybridization: an overview. Am J Pathol 1994; 145: 1253-1260.
13. Brodeur GM, Pritchard J, Berthold F, et al. Revisions of the international criteria for neuroblastoma diagnosis, staging and response to treatment. J Clin Oncol 1993; 11: 1466-1477.
14. Shimada A, Chatten J, Newton W, et al. Histopathologic prognostic factors in neuroblastic tumors: definition of subtypes of ganglioneuroblastoma and age-linked classification of neuroblastomas. J Natl Cancer Inst 1984; 73: 405-416.
15. Du Manoir S, Speicher R, Joos S, et al. Detection of complete and partial chromosome gains and losses by comparative genomic in situ hybridization. Hum Genet 1993; 90: 590-610.
16. Du Manoir S, Kallioniemi OP, Lichter P, et al. Hardware and software requirements for quantitative analysis of comparative genomic hybridization. Cytometry 1995; 19: 4-9.
17. Sauter G, Carrol P, Moch H, et al. c-myc number gains in bladder cancer detected by fluorescence in situ hybridization. Am J Pathol 1995; 146: 1131-1139.
18. Gilbert F, Feder M, Balaban G, et al. Human neuroblastomas and abnormalities of chromosomes 1 and 17. Cancer Res 1984; 44: 5444-5449.
19. Van Roy N, Laureys G, Cheng NC, et al. 1;17 translocations and other chromosome 17 rearrangements in human primary neuroblastoma tumors and cell lines. Genes Chrom Cancer 1994; 10: 103-114.
20. Layfield LJ, Thompson JK, Dodge RK, Kerns BJ. Prognostic indicators for neuroblastoma: stage, grade, DNA ploidy, MIB-1-proliferation index, p53, HER-2/neu and EGFr - a survival study. J Surg Omcol 1995; 59: 21-27.
21. Takayama H, Suzuki T, Mugishima H, et al. Deletion mapping of chromosomes 14q and 1p in human neuroblastoma. Oncogene 1992; 7: 1185-1189.
22. Christiansen H, Sahin K, Berthold F, Hero B, Terpe HJ, Lampert F. Comparison of DNA aneuploidy, chromosome 1 abnormalities, MYCN amplification and CD44 expression as prognostic factors in neuroblastoma. Eur J Cancer 1995; 31a: 541-544.
23. Weith A, Martinsson T, Cziepluch C, et al. Neuroblastoma consensus deletion maps to 1p36.1-2. Genes Chrom Cancer 1989; 1: 159-166.
24. Schleiermacher G, Peter M, Michon J, et al. Two distinct deleted regions of the short arm of chromosome 1 in neuroblastoma. Genes Chrom Cancer 1994; 10: 275-281.
25. Cheng NC, van Roy N, Chan A, Betsma M, Westerveld A, Speleman F. Deletion mapping in neuroblastoma cell lines suggests two distinct tumor suppressor genes in the 1p35-36 region, only one of which is associated with MYCN amplification. Oncogene 1995; 10: 291-297.
26. Piper J, Rutowitz D, Sudar D, et al. Computer image analysis of comparative genomic hybridization. Cytometry 1995; 19: 10-26.
27. Kallioniemi A, Kallioniemi OP, Piper J, et al. Comparative genomic hybridization for analysis of DNA sequence copy number changes in solid tumors. Genes Chrom Cancer 1994; 10: 231-234.
28. Corvi R, Amler LC, Saveleyeva L, Gehring M, Schwab M. MYCN is retained in single copy at chromosome 2 band p23-24 during amplification in human neuroblastoma cells. Proc Natl Acad Sci USA 1994; 91: 5523-5527.
29. Muresu R, Cascianu I, Volpi EV, Siniscalo M, Romani M. Cytogenetic and molecular studies on the neuroblastoma cell line NGP: identification of a reciprocal t(1;15) involving the 'consensus region' 1p36.1. Genes Chrom Cancer 1995; 13: 66-71.